Isobutyramide
Suppliers
Names
[ CAS No. ]:
563-83-7
[ Name ]:
Isobutyramide
[Synonym ]:
2-methylpropaneamide
EINECS 209-265-9
Propanamide, 2-methyl-
isopropylformamide
IBA
iso-Butyleneamine
isobutyrimidicacid
Isobutyramide
isobutyric amide
MFCD00008019
Isobuytramide
2-Methylpropanamide
anhydrous dimethyl-acetamide
Methyl propionic acid amide
VX 366
2-methylpropionamide
Chemical & Physical Properties
[ Density]:
0.9±0.1 g/cm3
[ Boiling Point ]:
221.4±8.0 °C at 760 mmHg
[ Melting Point ]:
127-131 °C(lit.)
[ Molecular Formula ]:
C4H9NO
[ Molecular Weight ]:
87.120
[ Flash Point ]:
87.7±18.4 °C
[ Exact Mass ]:
87.068413
[ PSA ]:
43.09000
[ LogP ]:
-0.36
[ Vapour Pressure ]:
0.1±0.4 mmHg at 25°C
[ Index of Refraction ]:
1.418
MSDS
Toxicological Information
CHEMICAL IDENTIFICATION
- RTECS NUMBER :
- TX1475000
- CHEMICAL NAME :
- Propanamide, 2-methyl-
- CAS REGISTRY NUMBER :
- 563-83-7
- BEILSTEIN REFERENCE NO. :
- 1737615
- LAST UPDATED :
- 199701
- DATA ITEMS CITED :
- 2
- MOLECULAR FORMULA :
- C4-H9-N-O
- MOLECULAR WEIGHT :
- 87.14
HEALTH HAZARD DATA
ACUTE TOXICITY DATA
- TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - species unspecified
- DOSE/DURATION :
- 3 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #5439939
Safety Information
[ Symbol ]:
GHS07
[ Signal Word ]:
Warning
[ Hazard Statements ]:
H302
[ Hazard Codes ]:
Xn
[ Risk Phrases ]:
22
[ Safety Phrases ]:
S24/25
[ RIDADR ]:
NONH for all modes of transport
[ WGK Germany ]:
3
[ RTECS ]:
TX1475000
[ HS Code ]:
2924199090
Synthetic Route
Precursor & DownStream
Precursor
DownStream
Customs
[ HS Code ]: 2924199090
[ Summary ]:
2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%
Articles
PLoS ONE 11 , e0145212, (2016)
Poor outcome in response to hepatitis C virus, including higher viral load, hepatocellular carcinoma and cirrhosis, is more associated with men and postmenopausal women than with premenopausal women a...
Blood 101(5) , 2001-7, (2003)
Pharmacologic stimulation of fetal hemoglobin (HbF) expression may be a promising approach for the treatment of beta-thalassemia. In this study, we have investigated the HbF-inducing activity and mole...
J. Mol. Endocrinol. 25(1) , 129-39, (2000)
To determine if ketoacidosis contributes to reduced apolipoprotein A1 (apoA1) expression in insulin-deficient diabetic rats, we examined the regulation of apoA1 gene expression in response to changes ...